Christopher Posner
Vermögen: 14 771 $ am 31.05.2026
Vermögen: 14 771 $ am 31.05.2026
Christopher A. Posner worked as Head-Worldwide Commercial Operations at R-Pharm US LLC from 2014 to 2017.
From 2017 to 2021, served as President & Chief Executive Officer at Leo Pharma, Inc. Served as Independent Director at CARA Therapeutics, Inc. from 2018 to 2021 and at Zevra Therapeutics, Inc. Education includes undergraduate studies at Villanova University and an MBA from The Fuqua School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,05 % | 28.02.2025 | 4.370 ( 0,05 % ) | 14 771 $ | 31.05.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Vorstandsvorsitzender | 01.10.2021 |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Corporate Officer/Principal | 01.01.2017 |
| ZEVRA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
| CARA THERAPEUTICS, INC. | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
CARA Therapeutics, Inc.
CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed | Health Technology |
Zevra Therapeutics, Inc.
Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Retail Trade |
The Fuqua School of Business
The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen